<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>02704nab a2200337 i 4500</leader>
  <controlfield tag="001">publ26787</controlfield>
  <controlfield tag="005">20230322133513.0</controlfield>
  <controlfield tag="008">230322s2023    hu      o     0||   Angol d</controlfield>
  <datafield tag="022" ind1=" " ind2=" ">
   <subfield code="a">2227-9059</subfield>
  </datafield>
  <datafield tag="024" ind1="7" ind2=" ">
   <subfield code="a">10.3390/biomedicines11030945</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="024" ind1="7" ind2=" ">
   <subfield code="a">33709302</subfield>
   <subfield code="2">mtmt</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
   <subfield code="a">SZTE Publicatio Repozitórium</subfield>
   <subfield code="b">hun</subfield>
  </datafield>
  <datafield tag="041" ind1=" " ind2=" ">
   <subfield code="a">Angol</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Polyák Helga</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="4">
   <subfield code="a">The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis</subfield>
   <subfield code="h">[elektronikus dokumentum] /</subfield>
   <subfield code="c"> Polyák Helga</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
   <subfield code="c">2023</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
   <subfield code="a">20</subfield>
  </datafield>
  <datafield tag="490" ind1="0" ind2=" ">
   <subfield code="a">BIOMEDICINES</subfield>
   <subfield code="v">11 No. 3</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Progressive multiple sclerosis (MS) is a chronic disease with a unique pattern, which is histologically classified into the subpial type 3 lesions in the autopsy. The lesion is also homologous to that of cuprizone (CPZ) toxin-induced animal models of demyelination. Aberration of the tryptophan (TRP)-kynurenine (KYN) metabolic system has been observed in patients with MS; nevertheless, the KYN metabolite profile of progressive MS remains inconclusive. In this study, C57Bl/6J male mice were treated with 0.2% CPZ toxin for 5 weeks and then underwent 4 weeks of recovery. We measured the levels of serotonin, TRP, and KYN metabolites in the plasma and the brain samples of mice at weeks 1, 3, and 5 of demyelination, and at weeks 7 and 9 of remyelination periods by ultra-high-performance liquid chromatography with tandem mass spectrometry (UHPLC-MS/MS) after body weight measurement and immunohistochemical analysis to confirm the development of demyelination. The UHPLC-MS/MS measurements demonstrated a significant reduction of kynurenic acid, 3-hydoxykynurenine (3-HK), and xanthurenic acid in the plasma and a significant reduction of 3-HK, and anthranilic acid in the brain samples at week 5. Here, we show the profile of KYN metabolites in the CPZ-induced mouse model of demyelination. Thus, the KYN metabolite profile potentially serves as a biomarker of progressive MS and thus opens a new path toward planning personalized treatment, which is frequently obscured with immunologic components in MS deterioration.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
   <subfield code="a">Klinikai orvostan</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Galla Zsolt</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Nánási Nikolett</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Cseh Edina Katalin</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Rajda Cecília</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Veres Gábor</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Spekker Eleonóra</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Szabó Ágnes</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Klivényi Péter</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Tanaka Masaru</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="0" ind2="1">
   <subfield code="a">Vécsei László</subfield>
   <subfield code="e">aut</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">http://publicatio.bibl.u-szeged.hu/26787/1/PolyakH._thetryptophan-kynureninemetabolicsystem....pdf</subfield>
   <subfield code="z">Dokumentum-elérés </subfield>
  </datafield>
 </record>
</collection>
